News

The trial results suggested that the drug was well tolerated at all dose levels and showed reduction in serotonin synthesis compared to placebo. The data from the study

The CRL was issued by the FDA in October 2010 for the NDA of the experimental type 2 diabetes drug Bydureon. In their reply, the companies have provided

Seasonique is a combination of female hormones that helps in preventing ovulation. Seasonique makes changes in the cervical mucus and uterine lining, to make it harder for sperm

FI6 is a neutralizing antibody which binds and neutralizes both Group 1 and Group 2 human and animal influenza A viruses. The researchers were able to culture single

Active pharmaceutical ingredients are delivered through pathogen cell walls using Phillips’ drug delivery technology. When the active pharmaceutical ingredients are combined with tetracycline, the resulting product is a

The instrument makes use of a software and E-Plates 96 to measure electronic cell impedance using sensor electrodes. Continual detection of changes in cell behavior using 96-well culture

In the trial, around 600 patients are expected to be enrolled who have failed prior systemic therapy. Further, the patients will be given weekly intramuscular injections of ADI-PEG

Peginesatide, a synthetic, PEGylated peptidic compound, is a erythropoiesis stimulating agent (ESA) that binds and activates the erythropoietin receptor. The NDA submission is based on data from two

Additionally, NIH has selected Viamet’s novel antifungal compounds for inclusion in the National Institutes of Health’s (NIH) Therapeutics for Rare and Neglected Diseases (TRND) program. Viamet president and